Vivos Therapeutics (VVOS) EBITDA Margin Growth (3y) (2023 - 2026)
Vivos Therapeutics (VVOS) EBITDA Margin Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | -201.00 |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 586.00 |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 78.00 |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 736.00 |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 887.00 |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 963.00 |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 212.00 |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 535.00 |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 244.00 |
| 10 | Vivos Therapeutics | 4.93 Mn | 3.13 Mn | 2.95 Mn | 4,229.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 109.00 |
| Dec 31, 2025 | -1,340.00 |
| Sep 30, 2025 | 5,755.00 |
| Jun 30, 2025 | 3,909.00 |
| Mar 31, 2025 | 5,228.00 |
| Dec 31, 2024 | 9,278.00 |
| Sep 30, 2024 | 5,253.00 |
| Jun 30, 2024 | 4,255.00 |
| Mar 31, 2024 | -1,192.00 |
| Dec 31, 2023 | 6,169.00 |
| Sep 30, 2023 | -5,506.00 |
| Jun 30, 2023 | -8,972.00 |
| Mar 31, 2023 | -4,975.00 |